Filing Details
- Accession Number:
- 0001104659-10-013792
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-11 12:00:00
- Reporting Period:
- 2010-03-09
- Filing Date:
- 2010-03-11
- Accepted Time:
- 2010-03-11 18:33:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1201580 | D Samuel Colella | C/O Versant Ventures 3000 Sand Hill Road, #4-210 Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-03-09 | 55,577 | $19.63 | 2,136,573 | No | 4 | S | Indirect | Versant Venture Capital I, L.P. |
Common Stock | Disposition | 2010-03-09 | 1,090 | $19.63 | 41,904 | No | 4 | S | Indirect | Versant Side Fund I, L.P. |
Common Stock | Disposition | 2010-03-09 | 1,075 | $19.63 | 41,337 | No | 4 | S | Indirect | Versant Affiliates Fund I-A, L.P. |
Common Stock | Disposition | 2010-03-09 | 2,258 | $19.63 | 86,808 | No | 4 | S | Indirect | Versant Affiliates Fund I-B, L.P. |
Common Stock | Disposition | 2010-03-10 | 43,257 | $19.21 | 2,093,316 | No | 4 | S | Indirect | Versant Venture Capital I, L.P. |
Common Stock | Disposition | 2010-03-10 | 848 | $19.21 | 41,056 | No | 4 | S | Indirect | Versant Side Fund I, L.P. |
Common Stock | Disposition | 2010-03-10 | 837 | $19.21 | 40,500 | No | 4 | S | Indirect | Versant Affiliates Fund I-A, L.P. |
Common Stock | Disposition | 2010-03-10 | 1,758 | $19.21 | 85,050 | No | 4 | S | Indirect | Versant Affiliates Fund I-B, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Versant Venture Capital I, L.P. |
No | 4 | S | Indirect | Versant Side Fund I, L.P. |
No | 4 | S | Indirect | Versant Affiliates Fund I-A, L.P. |
No | 4 | S | Indirect | Versant Affiliates Fund I-B, L.P. |
No | 4 | S | Indirect | Versant Venture Capital I, L.P. |
No | 4 | S | Indirect | Versant Side Fund I, L.P. |
No | 4 | S | Indirect | Versant Affiliates Fund I-A, L.P. |
No | 4 | S | Indirect | Versant Affiliates Fund I-B, L.P. |
Footnotes
- The Reporting Person is a managing member of Versant Ventures I, LLC ("VVI-LLC"), which is the general partner of each of Versant Side Fund I, L.P., Versant Venture Capital I, L.P., Versant Affiliates Fund I-A, L.P., and Versant Affiliates Fund I-B, L.P. (collectively, the "Versant Funds"). As such, the Reporting Person shares voting and investment power over the shares held by the Versant Funds and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such shares held by the Versant Funds, except to the extent of his proportionate pecuniary interest therein, if any.
- Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $19.34 to $20.10 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $19.07 to $19.52 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.